EAPIF
Price
$3.65
Change
-$0.09 (-2.41%)
Updated
Jul 15 closing price
Capitalization
1.11B
HLN
Price
$9.88
Change
+$0.03 (+0.30%)
Updated
Jul 25 closing price
Capitalization
38.4B
4 days until earnings call
Interact to see
Advertisement

EAPIF vs HLN

Header iconEAPIF vs HLN Comparison
Open Charts EAPIF vs HLNBanner chart's image
EUROAPI SA
Price$3.65
Change-$0.09 (-2.41%)
Volume$2.81K
Capitalization1.11B
Haleon
Price$9.88
Change+$0.03 (+0.30%)
Volume$9.88M
Capitalization38.4B
EAPIF vs HLN Comparison Chart in %
Loading...
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EAPIF vs. HLN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and HLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EAPIF: $3.65 vs. HLN: $9.88)
Brand notoriety: EAPIF and HLN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EAPIF: 135% vs. HLN: 73%
Market capitalization -- EAPIF: $1.11B vs. HLN: $38.4B
EAPIF [@Pharmaceuticals: Other] is valued at $1.11B. HLN’s [@Pharmaceuticals: Other] market capitalization is $38.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 0 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 0 green, 5 red.
According to our system of comparison, EAPIF is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EAPIF’s TA Score shows that 1 TA indicator(s) are bullish while HLN’s TA Score has 5 bullish TA indicator(s).

  • EAPIF’s TA Score: 1 bullish, 4 bearish.
  • HLN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HLN is a better buy in the short-term than EAPIF.

Price Growth

EAPIF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while HLN (@Pharmaceuticals: Other) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than EAPIF($1.11B). EAPIF has higher P/E ratio than HLN: EAPIF (476.19) vs HLN (29.23). EAPIF YTD gains are higher at: 21.667 vs. HLN (4.749). HLN has higher annual earnings (EBITDA): 2.35B vs. EAPIF (62.7M). HLN has higher revenues than EAPIF: HLN (11.3B) vs EAPIF (893M).
EAPIFHLNEAPIF / HLN
Capitalization1.11B38.4B3%
EBITDA62.7M2.35B3%
Gain YTD21.6674.749456%
P/E Ratio476.1929.231,629%
Revenue893M11.3B8%
Total CashN/A994M-
Total DebtN/A9.46B-
TECHNICAL ANALYSIS
Technical Analysis
EAPIFHLN
RSI
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
17%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
32%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
37%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PHD9.800.04
+0.41%
Pioneer Floating Rate Fund
FMDE35.220.14
+0.40%
Fidelity Enhanced Mid Cap ETF
IBMN26.770.01
+0.04%
iShares iBonds Dec 2025 Term Muni Bd ETF
HAIL32.56-0.05
-0.14%
SPDR® S&P Kensho Smart Mobility ETF
HYBX30.64-0.07
-0.21%
TCW High Yield Bond ETF

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+0.30%
HLNCF - EAPIF
11%
Poorly correlated
-0.51%
IXHL - EAPIF
7%
Poorly correlated
-35.58%
STEK - EAPIF
6%
Poorly correlated
-9.12%
CLSH - EAPIF
4%
Poorly correlated
N/A
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+0.30%
HLNCF - HLN
49%
Loosely correlated
-0.51%
TAK - HLN
36%
Loosely correlated
-1.23%
ZTS - HLN
30%
Poorly correlated
-0.46%
BHC - HLN
25%
Poorly correlated
N/A
VTRS - HLN
25%
Poorly correlated
+0.64%
More